Oxaliplatin 100 mg/20mL (Oxaliplatin INJECTION, SOLUTION, CONCENTRATE) 100 mg/20mL

Oxaliplatin 100 mg/20mL is an intravenous injection used in cancer treatment. This solution concentrate is manufactured by Teva Parenteral Medicines, Inc. in the USA.

Strength

100 mg/20mL

Pack Size

1 VIAL, SINGLE-USE in 1 CARTON (0703-3986-01) / 20 mL in 1 VIAL, SINGLE-USE

Manufacturer / TM Owner

Teva Parenteral Medicines, Inc.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Oxaliplatin 100 mg/20mL is a chemotherapy drug primarily used in the treatment of colorectal cancer. It is often combined with other medications to enhance effectiveness. The drug works by interfering with the growth and spread of cancer cells. What is Oxaliplatin used for? It is typically administered intravenously and is part of a broader cancer treatment plan.

Side Effects

Common effects of Oxaliplatin may include nausea, vomiting, diarrhea, and fatigue. Some patients may experience peripheral neuropathy, which can cause tingling or numbness in the hands and feet. These effects can vary in severity and duration. Always consult a healthcare provider for personalized advice.

Precautions & Warnings

Oxaliplatin should be handled with care, as it is a potent medication. It is important to follow proper storage and administration guidelines. Pregnant women and individuals with certain medical conditions should exercise caution. Always use under the supervision of a healthcare professional.

Avoid Interactions

Oxaliplatin may interact with other medications, including those that affect the immune system or blood clotting. It is important to inform your healthcare provider about all medications you are taking. Alcohol and certain supplements may also interact with Oxaliplatin, so it is advisable to avoid them unless directed otherwise.

Frequently Asked Questions

Oxaliplatin is used in the treatment of colorectal cancer, often in combination with other drugs.

Oxaliplatin is administered intravenously as an injection.

Common side effects include nausea, vomiting, diarrhea, fatigue, and peripheral neuropathy.

Pregnant women should exercise caution and consult a healthcare provider before using Oxaliplatin.

Avoid alcohol and certain supplements unless directed by a healthcare provider.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.